Association of <i>MMP9</i> and <i>NOS3</i> Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity. [PDF]
Osminina M +13 more
europepmc +1 more source
The efficacy and safety of tocilizumab in juvenile localised scleroderma patients: a retrospective cohort study in Eastern China. [PDF]
Shen Y +9 more
europepmc +1 more source
SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis [PDF]
Culpo R +19 more
europepmc +1 more source
Clinical Profile and Diagnostic Spectrum of Autoimmune Comorbidities in Juvenile Idiopathic Arthritis: A Descriptive Single-Centre Observational Study. [PDF]
Murgu AM +10 more
europepmc +1 more source
Upadacitinib for recalcitrant extragenital morphea and lichen sclerosus overlap: A case report. [PDF]
Rasul T +4 more
europepmc +1 more source
Clinical characteristics, autoantibody profiles, and therapeutic outcomes of juvenile systemic sclerosis: an 11-year single-center experience from China. [PDF]
Wang Y +5 more
europepmc +1 more source
Comparison of Systemic Corticosteroid Therapy Practices Between Pediatric and Adult Rheumatologists: A Multicenter Survey Study. [PDF]
Yağcı ÖÖ +4 more
europepmc +1 more source
Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review. [PDF]
Yu R +8 more
europepmc +1 more source
Idiopathic Calcinosis Cutis Universalis in a Child. [PDF]
Zouine O, Baybay H, Zaim A, Mernissi F.
europepmc +1 more source
PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients [PDF]
Culpo R +5 more
europepmc +1 more source

